Autopsy report · NCT04032756

Tofacitinib Registry of Patients With Ulcerative Colitis in Germany

“not enough patients recruited, Study objective could not be achieved”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 3 months before it stopped.
• 50 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Ced Service GmbH

Sponsor type

University, hospital or other

Conditions

Colitis, Ulcerative; Biologics; Tofacitiniib; Chronic Inflammatory Small Bowel Disease; Bowel Diseases, Inflammatory; Bowel Disease

Participants

50

Sites

1

Countries

Germany

Trials that died the same way

• Xenogenic Keratoplasty From Porcine Cornea
  “there was not enough patients recruited in this study” (83% match in meaning)
• A Single-center Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LCAR-L10D Cell Formulations Targeting CD19 and CD22 in Patients With CD19- and/or CD22-Positive Relapsed/Refractory B-cell Lymphoma
  “Suitable patients were not recruited” (77% match in meaning)
• Efficacy of EndoClot™ Spraying After Endoscopic Resection of Large Colorectal Polyps
  “insufficient recruitment of study patients” (75% match in meaning)
• Effects of Fish or Meat Consumption in Elderly
  “Not enough patients to recruite.” (72% match in meaning)
• Slings and Their Effect on Skin Pressure
  “unable to recruit patients for study” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.